Formyl peptide receptor 2 orchestrates mucosal protection against Citrobacter rodentium infection

References

• McGuckin MA, Linden SK, Sutton P, et al. Mucin dynamics and enteric pathogens. Nat Rev Microbiol. 2011;9(4):265–278. . Epub 2011/03/17; nrmicro2538 [pii]; PubMed PMID: 21407243
   PubMed Web of Science ®Google Scholar
• Johansson ME, Phillipson M, Petersson J, et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A. 2008;105(39):15064–15069. . PubMed PMID: 18806221; PubMed Central PMCID: PMC2567493
   PubMed Web of Science ®Google Scholar
• McGuckin MA, Every AL, Skene CD, et al. Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. Gastroenterology. 2007;133(4):1210–1218. . PubMed PMID: 17919495
   PubMed Web of Science ®Google Scholar
• Bergstrom KS, Kissoon-Singh V, Gibson DL, et al. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog. 2010;6(5):e1000902. . PubMed PMID: 20485566; PubMed Central PMCID: PMCPMC2869315
   PubMed Web of Science ®Google Scholar
• McAuley JL, Linden SK, Png CW, et al. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest. 2007;117(8):2313–2324. . PubMed PMID: 17641781; PubMed Central PMCID: PMCPMC1913485
   PubMed Web of Science ®Google Scholar
• Santos AS, Finlay BB. Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways. Cell Microbiol. 2015;17(3):318–332. . PubMed PMID: 25588886
   PubMed Web of Science ®Google Scholar
• Wales AD, Woodward MJ, Pearson GR. Attaching-effacing bacteria in animals. PubMed PMID: 15629476 J Comp Pathol. 2005;1321:1–26.
   PubMed Web of Science ®Google Scholar
• Luperchio SA, Schauer DB. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect. 2001;3(4):333–340. PubMed PMID: 11334751
   PubMed Web of Science ®Google Scholar
• Yang J, Tauschek M, Hart E, et al. Virulence regulation in Citrobacter rodentium: the art of timing. Microb Biotechnol. 2010;3(3):259–268. . PubMed PMID: 21255326; PubMed Central PMCID: PMCPMC3815369
   PubMed Web of Science ®Google Scholar
• Vallance BA, Finlay BB. Exploitation of host cells by enteropathogenic Escherichia coli. Proc Natl Acad Sci U S A. 2000;97(16):8799–8806. . PubMed PMID: 10922038; PubMed Central PMCID: PMCPMC34015
   PubMed Web of Science ®Google Scholar
• Gaytan MO, Martinez-Santos VI, Soto E, et al. Type three secretion system in attaching and effacing pathogens. Front Cell Infect Microbiol. 2016;6:129. . PubMed PMID: 27818950; PubMed Central PMCID: PMCPMC5073101
   PubMed Web of Science ®Google Scholar
• Navarro-Garcia F, Serapio-Palacios A, Ugalde-Silva P, et al. Actin cytoskeleton manipulation by effector proteins secreted by diarrheagenic Escherichia coli pathotypes. Biomed Res Int. 2013;2013:374395. . PubMed PMID: 23509714; PubMed Central PMCID: PMCPMC3591105
   PubMedGoogle Scholar
• Huet E, Boulay F, Barral S, et al. The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling. Cell Signal. 2007;19(9):1939–1948. . PubMed PMID: 17594911
   PubMed Web of Science ®Google Scholar
• Rabiet MJ, Huet E, Boulay F. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. Eur J Immunol. 2005;35(8):2486–2495. . PubMed PMID: 16025565
   PubMed Web of Science ®Google Scholar
• Dahlgren C, Gabl M, Holdfeldt A, et al. Basic characteristics of the neutrophil receptors that recognize formylated peptides, a danger-associated molecular pattern generated by bacteria and mitochondria. Biochem Pharmacol. 2016;114:22–39. . PubMed PMID: 27131862
   PubMed Web of Science ®Google Scholar
• Ye RD, Boulay F, Wang JM, et al. International union of basic and clinical pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev. 2009;61(2):119–161. . PubMed PMID: 19498085; PubMed Central PMCID: PMCPMC2745437
   PubMed Web of Science ®Google Scholar
• Chen K, Liu M, Liu Y, et al. Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis. J Clin Invest. 2013;123(4):1694–1704. . PubMed PMID: 23454745; PubMed Central PMCID: PMCPMC3613917
   PubMed Web of Science ®Google Scholar
• Gao JL, Lee EJ, Murphy PM. Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J Exp Med. 1999;189(4):657–662. PubMed PMID: 9989980; PubMed Central PMCID: PMCPMC2192926
   PubMed Web of Science ®Google Scholar
• Weiss E, Kretschmer D. Formyl-peptide receptors in infection, inflammation, and cancer. Trends Immunol. 2018;39(10):815–829. . Epub 2018/09/10; PubMed PMID: 30195466
   PubMed Web of Science ®Google Scholar
• Weiss E, Hanzelmann D, Fehlhaber B, et al. Formyl-peptide receptor 2 governs leukocyte influx in local Staphylococcus aureus infections. Faseb J. 2018;32(1):26–36. . Epub 2017/09/01; PubMed PMID: 28855276; PubMed Central PMCID: PMCPMC5731131
   PubMed Web of Science ®Google Scholar
• Becker EL, Forouhar FA, Grunnet ML, et al. Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells. Cell Tissue Res. 1998;292(1):129–135. PubMed PMID: 9506920
   PubMed Web of Science ®Google Scholar
• Rossi FW, Prevete N, Montuori N, et al. Hp(2-20) peptide of Helicobacter pylori and the innate immune receptors: specific role(s) of the formyl peptide receptors. Infez Med. 2012;20 Suppl 2:19–25. PubMed PMID: 23042002
   PubMedGoogle Scholar
• Babbin BA, Jesaitis AJ, Ivanov AI, et al. Formyl peptide receptor-1 activation enhances intestinal epithelial cell restitution through phosphatidylinositol 3-kinase-dependent activation of Rac1 and Cdc42. J Immunol. 2007;179(12):8112–8121. PubMed PMID: 18056353
   PubMed Web of Science ®Google Scholar
• Gronert K, Gewirtz A, Madara JL, et al. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release. J Exp Med. 1998;187(8):1285–1294. PubMed PMID: 9547339; PubMed Central PMCID: PMCPMC2212233
   PubMed Web of Science ®Google Scholar
• Chen K, Le Y, Liu Y, et al. A critical role for the g protein-coupled receptor mFPR2 in airway inflammation and immune responses. J Immunol. 2010;184(7):3331–3335. . PubMed PMID: 20200280
   PubMed Web of Science ®Google Scholar
• Navabi N, McGuckin MA, Linden SK. Gastrointestinal cell lines form polarized epithelia with an adherent mucus layer when cultured in semi-wet interfaces with mechanical stimulation. PLoS One. 2013;8(7):e68761. PubMed PMID: 23869232; PubMed Central PMCID: PMC3712011
   PubMed Web of Science ®Google Scholar
• Quintana-Hayashi MP, Linden SK. Differentiation of gastrointestinal cell lines by culture in semi-wet interface. Methods Mol Biol. 2018;1817:41–46. Epub 2018/ 07/01. PubMed PMID: 29959701.
   PubMedGoogle Scholar
• Gustafsson JK, Navabi N, Rodriguez-Pineiro AM, et al. Dynamic changes in mucus thickness and ion secretion during Citrobacter rodentium infection and clearance. PLoS One. 2013;8(12):e84430. . PubMed PMID: 24386378; PubMed Central PMCID: PMC3875541
   PubMed Web of Science ®Google Scholar
• Maiti AK, Sharba S, Navabi N, et al. IL-4 protects the mitochondria against TNFalpha and IFNgamma induced insult during clearance of infection with Citrobacter rodentium and Escherichia coli. Sci Rep. 2015;5:15434. . PubMed PMID: 26481427; PubMed Central PMCID: PMCPMC4613366
   PubMed Web of Science ®Google Scholar
• Bouladoux N, Harrison OJ, Belkaid Y. The mouse model of infection with Citrobacter rodentium. Curr Protoc Immunol. 2017;119:19 5 1–5 25. . PubMed PMID: 29091261; PubMed Central PMCID: PMCPMC5667658
   Google Scholar
• Eckmann L. Animal models of inflammatory bowel disease: lessons from enteric infections. Ann N Y Acad Sci. 2006;1072:28–38. . PubMed PMID: 17057188
   PubMed Web of Science ®Google Scholar
• Quintana-Hayashi MP, Navabi N, Mahu M, et al. Neutrophil elastase and IL17 expressed in the pig colon during Brachyspira hyodysenteriae infection synergistically with the pathogen induce increased mucus transport speed and production via MAPK3. Infect Immun. 2017. doi:10.1128/IAI.00262-17. PubMed PMID: 28559407.
   PubMed Web of Science ®Google Scholar
• Navabi N, Johansson ME, Raghavan S, et al. Helicobacter pylori infection impairs the mucin production rate and turnover in the murine gastric mucosa. Infect Immun. 2013;81(3):829–837. . PubMed PMID: 23275091; PubMed Central PMCID: PMCPMC3584886
   PubMed Web of Science ®Google Scholar
• Hang HC, Yu C, Kato DL, et al. A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation. Proc Natl Acad Sci U S A. 2003;100(25):14846–14851. . PubMed PMID: 14657396; PubMed Central PMCID: PMCPMC299823
   PubMed Web of Science ®Google Scholar
• Johansson ME. Fast renewal of the distal colonic mucus layers by the surface goblet cells as measured by in vivo labeling of mucin glycoproteins. PloS One. 2012;7(7):e41009. . PubMed PMID: 22815896; PubMed Central PMCID: PMC3398881
   PubMed Web of Science ®Google Scholar
• Leoni G, Alam A, Neumann PA, et al. Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. J Clin Invest. 2013;123(1):443–454. . PubMed PMID: 23241962; PubMed Central PMCID: PMCPMC3533303
   PubMed Web of Science ®Google Scholar
• Babbin BA, Laukoetter MG, Nava P, et al. Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J Immunol. 2008;181(7):5035–5044. PubMed PMID: 18802107; PubMed Central PMCID: PMCPMC2778483
   PubMed Web of Science ®Google Scholar
• Schroeder BO, Birchenough GMH, Stahlman M, et al. Bifidobacteria or fiber protects against diet-induced microbiota-mediated colonic mucus deterioration. Cell Host Microbe. 2018;23(1):27–40 e7. PubMed PMID: 29276171; PubMed Central PMCID: PMCPMC5764785. Epub 2017/ 12/26. .
   PubMed Web of Science ®Google Scholar
• Sharba S, Navabi N, Padra M, et al. Interleukin 4 induces rapid mucin transport, increases mucus thickness and quality and decreases colitis and Citrobacter rodentium in contact with epithelial cells. Virulence. 2019;10(1):97–117. . Epub 2019/01/23; PubMed PMID: 30665337; PubMed Central PMCID: PMCPMC6363059
   PubMed Web of Science ®Google Scholar
• Cattaneo F, Parisi M, Ammendola R. Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists. Int J Mol Sci. 2013;14(4):7193–7230. . PubMed PMID: 23549262; PubMed Central PMCID: PMCPMC3645683
   PubMed Web of Science ®Google Scholar
• Gabl M, Holdfeldt A, Sundqvist M, et al. FPR2 signaling without beta-arrestin recruitment alters the functional repertoire of neutrophils. Biochem Pharmacol. 2017;145:114–122. . Epub 2017/09/01; PubMed PMID: 28855087
   PubMed Web of Science ®Google Scholar
• Raabe CA, Groper J, Rescher U. Biased perspectives on formyl peptide receptors. Biochim Biophys Acta Mol Cell Res. 2019;1866(2):305–316. Epub 2018/ 12/07. PubMed PMID: 30521870.
   PubMed Web of Science ®Google Scholar
• Qin CX, May LT, Li R, et al. Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice. Nat Commun. 2017;8:14232. . Epub 2017/02/09; PubMed PMID: 28169296; PubMed Central PMCID: PMCPMC5309721
   PubMed Web of Science ®Google Scholar
• Malaviya R, Ikeda T, Ross E, et al. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature. 1996;381(6577):77–80. . PubMed PMID: 8609993
   PubMed Web of Science ®Google Scholar
• Goncalves NS, Ghaem-Maghami M, Monteleone G, et al. Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis. Infect Immun. 2001;69(11):6651–6659. . PubMed PMID: 11598034; PubMed Central PMCID: PMCPMC100039
   PubMed Web of Science ®Google Scholar
• Dann SM, Spehlmann ME, Hammond DC, et al. IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens. J Immunol. 2008;180(10):6816–6826. PubMed PMID: 18453602; PubMed Central PMCID: PMCPMC2696063
   PubMed Web of Science ®Google Scholar
• Hasnain SZ, Evans CM, Roy M, et al. Muc5ac: a critical component mediating the rejection of enteric nematodes. J Exp Med. 2011;208(5):893–900. . PubMed PMID: 21502330; PubMed Central PMCID: PMCPMC3092342
   PubMed Web of Science ®Google Scholar
• Kim SD, Kwon S, Lee SK, et al. The immune-stimulating peptide WKYMVm has therapeutic effects against ulcerative colitis. Exp Mol Med. 2013;45:e40. . PubMed PMID: 24030327; PubMed Central PMCID: PMCPMC3789265
   PubMed Web of Science ®Google Scholar
• Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2009;27:451–483. . PubMed PMID: 19105661
   PubMed Web of Science ®Google Scholar
• Prescott D, McKay DM. Aspirin-triggered lipoxin enhances macrophage phagocytosis of bacteria while inhibiting inflammatory cytokine production. Am J Physiol Gastrointest Liver Physiol. 2011;301(3):G487–G497. . PubMed PMID: 21659618
   PubMed Web of Science ®Google Scholar
• Maaser C, Housley MP, Iimura M, et al. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect Immun. 2004;72(6):3315–3324. . PubMed PMID: 15155635; PubMed Central PMCID: PMCPMC415672
   PubMed Web of Science ®Google Scholar
• Marasco WA, Phan SH, Krutzsch H, et al. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J Biol Chem. 1984;259(9):5430–5439. PubMed PMID: 6371005
   PubMed Web of Science ®Google Scholar